This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Network pharmacological analysis of corosolic acid reveals P4HA2 inhibits hepatocellular carcinoma progression
BMC Complementary Medicine and Therapies Open Access 29 May 2023
-
Nonviral mcDNA-mediated bispecific CAR T cells kill tumor cells in an experimental mouse model of hepatocellular carcinoma
BMC Cancer Open Access 25 July 2022
-
Emerging roles of a pivotal lncRNA SBF2-AS1 in cancers
Cancer Cell International Open Access 09 August 2021
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Related links
PowerPoint slides
Rights and permissions
About this article
Cite this article
Dawkins, J., Webster, R. The hepatocellular carcinoma market. Nat Rev Drug Discov 18, 13–14 (2019). https://doi.org/10.1038/nrd.2018.146
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd.2018.146